Macquarie Group’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,683
| Closed | -$290K | – | 2679 |
|
|
2021
Q3 | $290K | Hold |
1,683
| – | – | ﹤0.01% | 1750 |
|
|
2021
Q2 | $211K | Hold |
1,683
| – | – | ﹤0.01% | 1795 |
|
|
2021
Q1 | $228K | Sell |
1,683
-468
| -22% | -$60.5K | ﹤0.01% | 1674 |
|
|
2020
Q4 | $275K | Buy |
2,151
+900
| +72% | +$106K | ﹤0.01% | 1582 |
|
|
2020
Q3 | $141K | Sell |
1,251
-534
| -30% | -$53.2K | ﹤0.01% | 1697 |
|
|
2020
Q2 | $170K | Buy |
1,785
+854
| +92% | +$82.3K | ﹤0.01% | 1600 |
|
|
2020
Q1 | $84K | Sell |
931
-969
| -51% | -$75.3K | ﹤0.01% | 1685 |
|
|
2019
Q4 | $101K | Buy |
+1,900
| New | +$86.6K | ﹤0.01% | 1776 |
|
|
2018
Q4 | – | Sell |
-100
| Closed | -$6K | – | 2391 |
|
|
2018
Q3 | $6K | Sell |
100
-700
| -88% | -$34.4K | ﹤0.01% | 2056 |
|
|
2018
Q2 | $39K | Buy |
+800
| New | +$29.1K | ﹤0.01% | 1982 |
|
Macquarie Group's XLRN Position: Q4 2021 in Review
Macquarie Group sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,683 shares — an estimated $290K sold.
Macquarie Group first reported a position in XLRN in Q2 2018 and held it in 10 quarters. The position peaked at $290K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Macquarie Group reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Macquarie Group sold 1,683 Acceleron Pharma shares in Q4 2021, an estimated $290K.
- Macquarie Group first reported a position in Acceleron Pharma in Q2 2018 and held it in 10 quarters.
- Macquarie Group's Acceleron Pharma position peaked at $290K in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Macquarie Group's 13F filing for Q4 2021, filed 11 Feb 2022.